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Pancreatic Cancer (PC) is among the most difficult cancers to detect in its earliest stages 
when treatment is most effective. Factors that may contribute to PC include periodontal disease, 
smoking, chronic diabetes, obesity, immune factors, poor diet, chronic inflammation of the 
pancreas, gender and age. Understanding the relationship of oral pathogens due to periodontal 
disease may help reduce the risk for PC. In this research, we focused on bacteria that is 
associated with periodontal disease. Periodontal disease is one of the most common 
inflammatory diseases that affects the human body and is possibly correlated to PC. The oral 
cavity contains numerous bacteria including Porphyromonas gingivalis (P. gingivalis), 
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Aggregatibacter actinomycetemcomitans (Aa) and Fusobacterium Nucleatum (F. Nucleatum). P. 
gingivalis and Aa have the ability to penetrate in two different pathways into the pancreas. 
Firstly, oral bacteria can penetrate the gingival and alveolar tissue and reach the bloodstream. 
Lastly, oral bacteria that is swallowed can travel via gastrointestinal tract to the pancreas. These 
bacteria work in conjunction with each other and initiate an inflammatory response in the 
pancreas leading to the increased risk of PC. It is essential for dental healthcare professionals 
(DHP) to educate the public regarding oral risk factors such as periodontal disease that may 
increase the risk for PC. Preventing oral disease by encouraging good oral hygiene and the 
management of periodontal disease through non-surgical periodontal therapy by DHP may 
reduce oral pathogens and decrease the risk for PC. The DHP can make a difference by 
educating the public about the risk factors correlating to PCs. Further research into better early 
screening methods should include salivary markers and oral microbiome population as possible 
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What will it take to end cancer? The American Cancer Society employs many biomedical 
scientists and spends billions of dollars on research to answer this question. Pancreatic cancer 
(PC) is among the most difficult cancers to detect in its earliest stages when treatment is most 
effective. Cancer research, notably research into testing the oral microbiome, is of particular 
interest to dental healthcare professionals (DHP’s). The oral systemic link is a well-known area 
of research, particularly among dental healthcare professionals. How the oral microbiome may 
influence the risk for PC is the focus of our research. This subject aligns with the ADHA 
research objectives interprofessional education and oral health prevention. 
The intent of this research is to educate the DHP about PC, discover oral bacteria that 
may be related to PC and lastly, identify risk factors and oral health intervention that may be 




1. RECOGNIZE PANCREATIC CANCER SIGNS AND SYMPTOMS 
Pancreatic Cancer (PC) begins in the pancreas, an organ lying posterior to the lower part 
of the stomach.1 The pancreas is responsible for releasing enzymes that aid digestion and 
hormones such as insulin that help regulate the human metabolism of sugars.1 A clear sign of 
cancer is when the cells in the body mutate in their DNA, and this leads to an uncontrolled 
growth resulting in tumor formation.1 There are two categories of PC, the exocrine and the 
endocrine. Exocrine PC affects the cells that line the duct of the pancreas; it is recognized as 
pancreatic adenocarcinoma.1 The pancreatic endocrine type which is known as pancreatic 
neuroendocrine is the hormone producing cells of the pancreas. Each of these categories has its 
own types, symptoms, and prognosis. Adenocarcinoma, the exocrine PC, is the most common 
type of PC and is usually detected in the late stages of the disease.1 This research will focus more 
on the common exocrine type of PC. 
The American Cancer Society estimated in 2019 that 57,000 people were diagnosed with 
PC in 2020, and about 47,000 died, of the same disease.2 The average lifetime risk of PC in the 
United States is about 1 in 64.2 In the United States, exocrine PC accounts for three percent of all 
cancers and seven percent of all cancer-related deaths.2 This type of cancer is more common in 
men than in women and is seldomly discovered in the early stages when it is most curable.2 The 
disease slowly metastasizes to other organs, and that is when the cancer signs and symptoms are 
revealed. 
Exocrine PC may exhibit symptoms that include but are not limited to fatigue, blood 
clots, the skin becomes yellow, and the eyes turn white (also known as jaundice) light colored 
stools and dark colored urine, abdominal pain that radiates to the back, loss of appetite that 
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causes weight loss, and pruritis.1 Confounding symptoms may result in a misdiagnosis of 
diabetes or an inability to maintain a current diabetic condition. As the disease progresses many 
complications can appear, such as weight loss. This happens because as the tumor grows it puts 
pressure in the stomach and effects the eating process. Also, the digestion of enzymes is 
disturbed, making it difficult for the body to process the food nutrients.1 Another complication is 
jaundice, and this occurs when the cancer cells grow and obstruct the liver’s bile duct.1 
Furthermore, as PC grows it puts pressure on the nerves that innervate the abdominal region, 
resulting in severe pain.1 
The Mayo Clinic recognizes several risk factors for PC. Modifiable risk factors include 
smoking, chronic diabetes, obesity, and chronic inflammation of the pancreas. Non-modifiable 
risk factors include gender and age.1 According to the American Cancer Society, men are twice 
as likely to be diagnosed with PC than women, and there is an increased risk for people over the 
age of sixty-five.2 Generally, physicians agree that any combination of these modifiable and non-
modifiable risk factors may increase the risk for PC.2 
The oral cavity contains numerous species of bacteria, and the presence of different types 
of bacteria in the oral cavity is associated with periodontal disease.3 Due to the inflammatory 
process of periodontitis, systemic conditions such as PC has been linked. Periodontitis is among 
one of the most common inflammatory diseases that affects the human body.4 According to the 
Center for Disease Control, 47.2% of adults over 30 years suffer from some type of periodontal 
disease.4 Also, with age, the risk increases to 70.1% of adults over 65 are diagnosed with 
periodontal disease.4 Similar to PC, periodontitis mainly affects men (56.4%) rather than women 
(38.4%) and smokers (64.2%).4 
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It has been reported that periodontal disease affects 90% of the world population.5  This 
shows that periodontitis is a very common disease and understanding its association with PC 
may impact a patient’s overall health. For many years, the pancreas was considered to be free of 
pathogens because it contained alkaline solution.6 In 2013, Michaud found that microorganisms 
may reach the pancreas through blood and the digestive system.6 The presence of oral pathogens 
in the pancreas may disturb the alkaline environment and initiate an inflammatory response 
within the pancreas.6 
The body’s inflammatory response to periodontal pathogens may influence the pancreas 
regulation of blood sugar and increase the risk for PC. Diagnosing PC in its earliest stages is 
particularly challenging. Diagnosis and treatment of periodontal disease and removal of 
periodontal pathogens may assist in reducing the risk for PC.7, 8 In order to help with a better 
outcome of this disease, oral health habits based on patient knowledge, attitudes, and practices 




2. DISCUSS PERIODONTAL PATHOGENS ASSOCIATED WITH 
PANCREATIC CANCER 
Biofilm accumulation of microorganisms is what results in the formation of pellicle on 
the teeth and serves as a source to initiate inflammation in the mouth. Progression of gingivitis, 
which is an inflammation of the gingival tissue, is what leads to periodontitis. In the Journal of 
Oral Microbiology by Olsen et. al study showed there is a relationship between inflammation 
and the incidence of pancreatic cancer.10 Research indicates there are specific oral microbial 
bacterium that activates an immune system response.7 Oral microbial bacterium has the ability to 
travel through GI tract and the oral cavity by penetrating into the alveolar bone reaching the 
bloodstream.7 The oral environment is very important when it comes to human health. Oral 
microbial bacterial attach to epithelial cells within the gingiva and disrupts their metabolism.7 It 
is very important that the number of oral pathogens are reduced in order to maintain oral 
environmental balance.7 An imbalance of the oral environment could potentially change the 
body’s immune response to stimulate and secrets the inflammatory mediators which could 
initiate PC.7 
There are several oral microbiome bacteria associated with periodontal disease, but this 
research will mainly focus on Porphyromonas gingivalis (P. gingivalis) and Aggregabacter 
actinomycetemcomitans (Aa). The presence of P. gingivalis and Aa. destroys the periodontium, 
and this may initiate the risk of PC. In a 2013 study conducted by Michaud et al., 405 individuals 
with pancreatic cancer levels of antibodies were tested against P. gingivalis, and these levels are 
higher compared to the healthy individual antibody levels.7,9 
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According to Henderson et al., 2010. Aa., a gram-negative non-motile facultative 
anaerobe bacterium, has the potential to travel into the host cells by endocytosis. In the host cell, 
it releases phospholipase C, which damages the membrane vesicles and let go of themselves 
ending up in the cytoplasm.6 There is a growth and division after this vigorous process, whereby 
anchoring to the host cell membrane.6 Aa, then infiltrates the adjacent epithelia cells or deep cells 
through microtubules.6 This process enables Aa. to infect deep cells and escape from the immune 
system.6 Aa. is capable of releasing a toxin known as Leukotoxin (LtxA), a lipoprotein that 
attaches to neutrophils, monocytes, and lymphocytes.6 The end results is forming pores on the 
cell membrane, thereby changing and altering its function of osmotic homeostasis, leading to cell 
death.6 
According to Fan et. al., P. gingivalis was considered as having the ability to invade the 
immune system and damage the signaling pathways through cytokine and receptor degradation. 
Aa. on the other hand, is capable of initiating the Toll-like receptor (TLR) signaling pathways, 
which is crucial in promoting PC.1,7 In 2018, a prospective experimental study conducted by Fan 
et al., demonstrated the relationship between PC and oral microbes by testing saliva mouth wash 
samples collected from participants. Oral mouth wash samples were collected from 361 men and 
women with PC and compared with 371 healthy individuals.10 The mouth wash samples were 
characterized with 16S rRNA gene sequencing. A group of organisms were evaluated based on 
the phylogenetic similarity of the bacteria abundance, the presence or absence using operational 
taxonomic units (OTUs). The participants were monitored very closely for nearly a decade 
between subjects to determine who developed pancreatic cancer.7,10 Participants with P. 
gingivalis in their oral microbiome had a 59% higher risk of developing PC than those 
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without.7,10 Individuals with Aa. had at least 50% higher risk of developing PC.7,10 The results 
indicated P. gingivalis and Aa. are associated with an increased risk of PC.7,10 
Also P. gingivalis and Aa. may work in concert to increase the risk of PC. The process 
known as the bacteria driver passenger model explains the pathogenic process. Initial bacteria, in 
this case Aa., damages the DNA of the host cell. The rapid changes in the host cells 
microenvironment created by Aa. result in an increase for F. nucleatum to create a more stable 
ecosystem for the pathogens. Consequently, the formation of non-pathogenic “passenger” 
bacteria like F. nucleatum acts as a bridging organism between cancer cells and Aa. Aa. is active 
in the early inflammation response, and as the disease progress, P. gingivalis hinders the cancer 
cells apoptosis and promotes tumor development.6 
This combination of periodontal pathogens may play a role in increasing the risk of PC.6 
Thus, the different microbial ecosystem is stable and more toxic in their environment.6 This 
could be one of the significant factors in potentially resulting in PC.6 Early detection of P. 
gingivalis and Aa. along with treatment of periodontal disease may help reduce a patient’s risk 




3. IDENTIFY DENTAL HEALTH PROFESSIONAL’S ROLE IN 
REDUCING ORAL HEALTH RISK FOR PANCREATIC CANCER 
Dental Health Professional’s (DHP’s) role in preventing disease in the oral environment 
is by conducting a non-surgical periodontal therapy. This therapy consists of the removal of 
dental biofilm and calculus from the oral cavity by scaling with hand scalers, curettes and/or the 
use of ultrasonic instrumentation.12 These instruments will help in the removal of supragingival 
and subgingival biofilm and calculus and altering oral microbiota. Patients who suffer from 
chronic periodontal disease might require surgical periodontal therapy by DHP’s. This consists 
of an open flap debridement in which part of the gingival is surgically separated to visibly access 
subgingival and debride lesions by reducing biofilm and calculus accumulation in deep 
periodontal pockets.12 The American Dental Association recommends periodontal disease to be 
treated by reducing inflammation, arrest disease progression, and provide patient with oral 
hygiene instructions such as brushing two times daily for 2 minutes with a soft bristle brush, 
cleaning interproximal with dental floss, using toothpaste that contains fluoride and professional 
prophylaxis at follow up visits this will help in maintaining good oral hygiene.12 
Preventing oral disease by encouraging good oral hygiene and the management of 
periodontal disease by reducing oral pathogens such as P. gingivalis and Aa will mitigate the risk 
for PC.11 Since the absence of oral pathogens will not initiate an immune response, this will 
reduce the risk for the development of inflammation in other parts of the body, such as the 
pancreas. 
In a cross-sectional study by Farrell et al., a method that can potentially be used in the 
future for the detection of periodontal pathogens that can be linked to the increased risk for PC is 
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microbial gathering using the Human Oral Microbe Identification Microarray.3 This study was 
conducted to demonstrate the variations of salivary microbiota and the association between oral 
disease and the increased risk of PC.3 In this study, all subjects were gathered from the UCLA 
Medical Center where 103 saliva pellet samples containing 38 PC, 38 healthy control, and 27 
chronic pancreatitis samples were selected.3 This study had a discovery phase and a verification 
phase to an independent validation phase.3 20 pellet samples with salivary microflora were 
profiled by the HOMIM array, 10 patients with PC and 10 healthy control subjects.3 Following, 
an independent sample set was used including 27 patients with chronic pancreatitis, 28 patients 
with PC and 28 healthy controls for the biomarker validation phase using a qPCR test.3 The 
outcome of the study showed a significant variation of microflora in the saliva of patients with 
PC(n=10) in comparison to healthy control subjects(n=10).3 31 species/clusters were shown in 
the saliva pellets of patients who had PC in contrast healthy control subjects(n=10) 25 
species/clusters were less.3 These species/clusters shown in the saliva pellets were from the 
Firmicutes, Proteobacteria, CFB group bacteria, and Actinobacteria.3 In the independent 
validation bacterial biomarkers phase, 2 microbial biomarkers, N elongate and S mitis, 
demonstrated a significant difference in patients with PC and healthy control (p<0.05, n=56).3 
This indicated that  the levels of these bacterial biomarkers were less in a patient with 
PC(n=28)than in healthy control subject(n=56)(p<0.05).3 This study demonstrated that profiling 
saliva and the detection of biomarkers in saliva can result in a credible tool for the early 
detection of cancer and improve survival rates for PC.3 In addition, DHP’s can use this method in 
order to detect oral pathogens and inform patients about the increase risk for PC. 
Modifiable risk factors such as smoking, diabetes, and obesity may also trigger PC and it 
is essential to inform patients of the risk for cancer if these factors are not changed or controlled 
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in addition to poor oral hygiene.1 For example, DHP’s can educate the patient of the increase risk 
for smoking and provide information about tobacco cessation which may reduce the risk for 
disease. Also, educating the diabetic population about the importance of having a controlled 
blood sugar and its association to periodontal disease can help reduce the risk for PC. Another 
important point is to promote healthy eating habits for the overweight population such as a diet 
full of fruits and vegetables and whole grain meals, which may help reduce the risk for PC.1 
The importance of creating awareness by educating the DHP’s about pancreatic cancer 
and its association to oral health may lead to the prevention of PC. Since periodontitis is linked 
to increase risk for pancreatic cancer, the dental profession should take responsibility to inform 
and educate patients about the risk. Further research is essential to learn about more screening 





PC is a fatal disease that is hard to diagnose since cancer cells metastasizes to other 
organs and that is when the cancer signs and symptoms are revealed. One of the factors that 
contributes to increase risk to PC is periodontal disease. By understanding the relationship of 
oral pathogens in periodontal disease such as P. gingivalis and Aa this may mitigate the risk for 
PC. In addition, recognizing modifiable risk factors such as smoking, diabetes, periodontal 
disease, obesity and non-modifiable risk factors such as age and genetics may help in the 
prevention of the development of disease. The DHP’s may play a vital role in decreasing the 
morbidity and mortality rate from one of the deadliest cancers by providing non-surgical 
periodontal therapy, using potential tools such as saliva microbial profiling, tobacco cessation, 
controlled diabetes’s, educating and promoting good oral hygiene as well as recommending well 
balanced diet may reduce the risk for PC. Further research is needed to identify additional risk 
factors, in order to recognize high risk individuals for PC and screening methods for the early 
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